Programmed death-1 or programmed death ligand-1 inhibitors? A meta-analysis of differential efficacy as compared to chemotherapy in advanced non-small cell lung cancer.

Hakan Bozcuk,Mehmet Artac,Hasan Mutlu,Ozlem Nuray Sever,Mustafa Yildirim

Programmed death-1 or programmed death ligand-1 inhibitors? A meta-analysis of differential efficacy as compared to chemotherapy in advanced non-small cell lung cancer.

2020

Hakan Bozcuk
Mehmet Artac
Hasan Mutlu
Ozlem Nuray Sever
Mustafa Yildirim

BackgroundProgrammed Death-1 (PD-1) and Programmed Death Ligand-1 (PDL-1) inhibitors have improved survival over chemotherapy in advanced Non- Small Cell Lung Cancer (NSCLC). However, it is unclear...

Keywords:

Lung cancer
immune checkpoint inhibitors
Oncology
Internal medicine
Confidence interval
Meta-analysis
Hazard ratio
Chemotherapy
programmed death
non small cell
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations